Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2023-04-06 2023-04-06
Drug Identification Number 02229099 02229099
Brand name PULMICORT NEBUAMP 0.125 MG/ML PULMICORT NEBUAMP 0.125 MG/ML
Common or Proper name budesonide budesonide
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients BUDESONIDE BUDESONIDE
Strength(s) 0.125MG 0.125MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 20 ampoules 20 ampoules
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-15 2023-02-15
Estimated end date 2023-04-05 2023-04-05
Actual end date 2023-04-05 2023-04-05
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments